BridgeBio’s Attruby™ (acoramidis) approved by FDA to reduce cardiovascular death and cardiovascular-related hospitalization in ATTR-CM patients

READ MORE  ►

OneSkin closes $20M series A investment round, fueling the future of skin longevity with advanced research

READ MORE  ►

Jupiter Bioventures raises $70M fund for super early science

READ MORE  ►

Myka Labs partners with Mayo Clinic to develop next-gen AI for surgery

READ MORE  ►

Siren Biotechnology Reveals SRN-101 as Lead Asset for High-Grade Gliomas with Both Orphan Drug and Rare Pediatric Disease Designations from the FDA

READ MORE  ►

Delve Bio announces launch of its genomic infectious disease test, Delve Detect

READ MORE  ►

Vevo Therapeutics to release world's largest atlas of single-cell transcriptomic data, Tahoe-100M, to map how drugs impact patient cells and accelerate discovery of new drugs

READ MORE  ►

Nuvig Therapeutics announces $161M series B financing and progression to phase 2 development with novel, second-generation immunomodulator

READ MORE  ►

Alumnus Spotlight on Meet Vora - From Single Bench to Sensor Scale

READ MORE  ►

New Instrument Crash Course: HVITA System

December 10 @ 12:30pm - 1:30pm

135 Mississippi, San Francisco, Flourine Conference Room,

We are excited to announce the placement the Hvita perfusion based organoid culture system for more consistent organoid growth and Organ-on-a-Chip research in our cores!  

Join our partners at ALIT LifeTech for an informative introduction on the applications supported by the Hvita system.

REGISTER  ►

Life Science Vendor’s Showcase

December 11 @ 10am - 2pm

930 Brittan Ave, San Carlos

Struggling to streamline your operations or scale your innovations effectively? Or perhaps you’re looking to plan ahead for growth and explore the solutions available to support your journey? Mark your calendars for another showcase at our San Carlos location, where you’ll meet vendors offering solutions tailored to your needs.

Mexican food from El Almancer’s food truck will be available for lunch - no RSVP is required.

READ MORE  ►

Sift is developing next-generation immune boosters using AI and microbial memory.

Sift Biosciences combines AI with high-throughput antigen screening to develop next-generation immunomodulators. The company’s immune boosters can supercharge anti-cancer responses, with the goal of delivering lasting remissions to patients.  

We warmly welcome CEO Clare Lou and CSO Maddie Williams to our 733 Industrial community in San Carlos!

READ MORE  ►

EverTree Bio is a preclinical stage, all-in-human, neurological drug discovery company. They leverage their proprietary stem cell-based human tissue engineered platform to unlock new targets and drugs for neurological diseases at scale. Their lead asset aims to restore neuronal health and reduce neuroinflammation for CMT1A, ALS, and Multiple Sclerosis.

We are proud to have co-founders Mikayla Richter, Sarah Kishinevsky and Ryan Samuel in our 135 Mississippi Street community in San Francisco.